[Sphingolipids and malignant growth].
Data concerning qualitative and quantitative changes in sphingolipids (ceramides, sphingomyelins, glycolipids) occurring under cell malignization are reviewed. The influence of these changes on biological functions of cell membranes and immunity as well as "sphingolipid" therapy of tumours are discussed.
Diatlovitskaia
E V
EV
D002462:Cell Membrane / Q000378:metabolism; D002471:Cell Transformation, Neoplastic; D009369:Neoplasms / Q000188:drug therapy; D013107:Sphingolipids / Q000378:metabolism* / Q000627:therapeutic use
D013107:Sphingolipids
Sfingolipidy i zlokachestvennyĭ rost.